• Annals of surgery · Jan 2022

    Randomized Controlled Trial Multicenter Study

    Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh with Primary Perineal Wound Closure after Extralevator Abdominoperineal Resection (BIOPEX-study).

    • Robin D Blok, Sarah Sharabiany, Jaap Stoker, Ellen T M Laan, BoskerRobbert J IRJIDepartment Surgery, Deventer Hospital, Deventer, the Netherlands., BurgerJacobus W AJWADepartment of Surgery, Catharina Hosp... more ital, Eindhoven, the Netherlands., Sanjay Chaudhri, Peter van Duijvendijk, Boudewijn van Etten, van GelovenAnna A WAAWDepartment of Surgery, Tergooi Hospital, Hilversum, the Netherlands., de GraafEelco J REJRDepartment of Surgery, IJsselland Hospital, Capelle aan de IJssel, the Netherlands., Christiaan Hoff, Roel Hompes, LeijtensJeroen W AJWADepartment of Surgery, St. Laurentius Hospital, Roermond, the Netherlands., Joost Rothbarth, RuttenHarm J THJTDepartment of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Baljit Singh, VuylstekeRonald J C L MRJCLMDepartment of Surgery, Spaarne Gasthuis, Haarlem, the Netherlands., de WiltJohannes H WJHWDepartment of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands., DijkgraafMarcel G WMGWDepartment of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Willem A Bemelman, Gijsbert D Musters, and Pieter J Tanis. less
    • Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
    • Ann. Surg. 2022 Jan 1; 275 (1): e37e44e37-e44.

    ObjectiveTo determine long-term outcomes of a randomized trial (BIOPEX) comparing biological mesh and primary perineal closure in rectal cancer patients after extralevator abdominoperineal resection and preoperative radiotherapy, with a primary focus on symptomatic perineal hernia.Summary Background DataBIOPEX is the only randomized trial in this field, which was negative on its primary endpoint (30-day wound healing).MethodsThis was a posthoc secondary analysis of patients randomized in the BIOPEX trial to either biological mesh closure (n = 50; 2 dropouts) or primary perineal closure (n = 54; 1 dropout). Patients were followed for 5 years. Actuarial 5-year probabilities were determined by the Kaplan-Meier statistic.ResultsActuarial 5-year symptomatic perineal hernia rates were 7% (95% CI, 0-30) after biological mesh closure versus 30% (95% CI, 10-49) after primary closure (P = 0.006). One patient (2%) in the biomesh group underwent elective perineal hernia repair, compared to 7 patients (13%) in the primary closure group (P = 0.062). Reoperations for small bowel obstruction were necessary in 1/48 patients (2%) and 5/53 patients (9%), respectively (P = 0.208). No significant differences were found for chronic perineal wound problems, locoregional recurrence, overall survival, and main domains of quality of life and functional outcome.ConclusionsSymptomatic perineal hernia rate at 5-year follow-up after abdominoperineal resection for rectal cancer was significantly lower after biological mesh closure. Biological mesh closure did not improve quality of life or functional outcomes.Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

      Pubmed     Full text   Copy Citation  

      Add institutional full text...

    Notes

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.